Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Engulfment and Cell Motility 3 (ELMO3) (C-Term) Peptide

ELMO3 Reactivity: Human Host: Synthetic BP, WB
Catalog No. ABIN8099642
$145.08
Plus shipping costs $50.00
100 μg
Shipping to: United States
Delivery in 2 to 4 Business Days

Quick Overview for Engulfment and Cell Motility 3 (ELMO3) (C-Term) Peptide (ABIN8099642)

Target

ELMO3 (Engulfment and Cell Motility 3 (ELMO3))

Origin

Human

Source

  • 6
Synthetic

Application

Blocking Peptide (BP), Western Blotting (WB)
  • Protein Region

    C-Term

    Purpose

    ELMO3 Peptide - C-terminal region

    Sequence

    TLALKPTSLE LFRTKVNALT YGEVLRLRQT ERLHQEGTLA PPILELREKL
  • Application Notes

    Optimal working dilution should be determined by the investigator.

    Comment

    This is a synthetic peptide designed for use in combination with anti-ELMO3 Antibody (ARP42636_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.

    Restrictions

    For Research Use only
  • Format

    Lyophilized

    Reconstitution

    Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.

    Buffer

    Lyophilized powder

    Storage

    -20 °C

    Storage Comment

    For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
  • Target

    ELMO3 (Engulfment and Cell Motility 3 (ELMO3))

    Background

    The protein encoded by this gene is similar to a C. elegans protein that functions in phagocytosis of apoptotic cells and in cell migration. Other members of this small family of engulfment and cell motility (ELMO) proteins have been shown to interact with the dedicator of cyto-kinesis 1 protein to promote phagocytosis and effect cell shape changes.

    Molecular Weight

    66kDa

    Gene ID

    79767

    UniProt

    Q96BJ8
You are here:
Chat with us!